New Leaf Ventures III, L.P.
SEC-identified person · CIK 1625653 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Harpoon Therapeutics, Inc. HARP | Director | filed 2019–2024 |
| Deciphera Pharmaceuticals, Inc. NA | Officer | filed 2017–2019 |
| Arvinas, INC. AVRN | Officer | filed 2018–2018 |
| Aptinyx Inc. APTX | Officer | filed 2018–2018 |
| Iterum Therapeutics plc ITRM | Officer | filed 2018–2018 |
| PDS Biotechnology Corp PDSB | Director | filed 2016–2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.